CRT-P is sufficient in Most Patients Needing Resynchronization

Volume 2, Jan 2013

Amit Vora MD, DM, DNB, Mumbai, India

The recent 2012 updated device guidelines (1) state that cardiac resynchronization therapy (CRT) is Class IA indication in patients with left ventricular ejection fraction (LVEF) < 0.35, in SR, LBBB with QRS width of >150 ms, those who are in NYHA III-IV, despite optimal medical therapy. The dilemma clinicians face is, should CRT be supplemented with implantable cardioverter defibrillator (ICD) (as primary prophylaxis). In this review, we apply evidence based knowledge and rationale to address this question.

Volume 2, Number 1, Pages: 29-31